The AlphaLISA™ SureFire® Ultra™ Human and Mouse Phospho-Raf-1 (Ser259) assay is a sandwich immunoassay for quantitative detection of phospho-Raf-1 in cellular lysates using Alpha technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Cell Signaling |
Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Ultra™ Human and Mouse Phospho-Raf-1 (Ser259) assay is a sandwich immunoassay for quantitative detection of phospho-Raf-1 in cellular lysates using Alpha technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
RAF proto-oncogene serine/threonine-protein kinase has numerous aliases, including Raf-1, c-Raf, and proto-oncogene c-RAF. Raf-1 is an enzyme belonging to the subfamily of membrane associated GTPases. Raf-1 is a principal component of the mitogen-activated protein kinase (MAPK) pathway, specifically the ERK1/2 signaling cascade 1. Raf-1 regulates cell growth and division, playing a key role in cell proliferation. It is also involved in cell survival pathways and metabolic processes within cells. This protein is associated with various cancers, including bladder urothelial carcinoma, skin cutaneous melanoma, and uterine corpus endometrial carcinoma.
The AlphaLISA SureFire Ultra Human and Mouse Phospho-Raf-1 (Ser259) Detection Kit is a sandwich immunoassay for the quantitative detection of phospho-Raf-1 in cellular lysates, using Alpha technology.
Formats:
AlphaLISA SureFire Ultra kits are compatible with:
Alpha SureFire kits can be used for:
Application |
Cell Signaling
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA SureFire Ultra
|
Detection Modality |
Alpha
|
Host Species |
Human
Mouse
|
Lysis Buffer Compatibility |
Lysis Buffer
|
Molecular Modification |
Phosphorylation
|
Product Group |
Kit
|
Sample Volume |
10 µL
|
Shipping Conditions |
Shipped in Blue Ice
|
Target |
Raf-1
|
Target Class |
Phosphoproteins
|
Target Species |
Human
Mouse
|
Technology |
Alpha
|
Therapeutic Area |
Oncology
|
Unit Size |
50,000 Assay Points
|
HeLa cells were seeded in a 96-well plate(40,000 cells/well) in complete medium, and incubated overnight at 37°C, 5% CO2. The cells were treated for 24 hours with increasing concentrations of Geldanamycin prepared in serum free medium containing 1% FBS.
After treatment, the cells were lysed with 100µL of lysis buffer for 10 minutes at RT with shaking (350 rpm). Raf-1 Phospho (Ser259) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate(approximately 4,000 cells) were transferred into a 384-well white OptiPlate, followed by 5µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus™ using standard AlphaLISA settings.
As expected, Geldanamycin (HSP90 inhibitor, disrupts the Raf-1-HSP90 complex) triggered a dose-dependent decrease in the levels of Raf-1 Phospho (Ser259) and Total.
Raf-1 or Raf-1 p-S259 peptides were titrated into a fixed dilution of positive control lysate (HeLa cells treated with 200 ng/mL PMA). RAF1 Phospho (Ser259) levels were evaluated by AlphaLISA SureFire Ultra. For the detection step, 10 µL of peptide mix was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus using standard AlphaLISA settings.
Phospho Raf-1 (Ser259) levels were assessed in HeLa cells (WT) and Raf-1 knockout (KO) HeLa cells. Raf-1 KO cells (Abcam ab264978) and WT-HeLa cells were cultured to confluency in T25 flasks in complete medium at 37°C, 5% CO2.
Each flask was lysed in 2 mL of lysis buffer for 10 minutes at RT with shaking (350 rpm). Phospho Raf-1 (Ser259) levels were then evaluated by AlphaLISA SureFire Ultra. For the detection step, 10 µL of cell lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus using standard AlphaLISA settings. As expected, Phospho Raf-1 (Ser259) was detected in the WT-Hela cells but not in the Raf-1 KO cell line.
Are you looking for resources, click on the resource type to explore further.
Quantifying H3K9ac in Cellular Extracts with AlphaLISA
This technical note gives you details about how AlphaLISA immunodetection...
Quantification of H3K27me3 Levels Using AlphaLISA Technology
In this technical note discover how AlphaLISA™ immunodetection assay...
Unlocking the secrets of epigenetics, our technical not dives into optimizing a DOT1L enzymatic assay
This technical document...
AlphaLISA ™ Detects β2-Microglobulin in Urine with High Sensitivity
When kidney tubular function is impaired, elevated levels of β2...
AlphaLISA KAT5 (TIP60) Assay for Detecting Histone H4 Acetylation
In this technical note, you will discover how this AlphaLISA™...
The Assessment of the Potential Hepatotoxicity of New Drugs by In Vitro Models
Liver toxicity is a significant concern during drug...
We are here to answer your questions.